(19)
(11) EP 2 997 031 A1

(12)

(43) Date of publication:
23.03.2016 Bulletin 2016/12

(21) Application number: 14732453.7

(22) Date of filing: 16.05.2014
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
(86) International application number:
PCT/PL2014/000053
(87) International publication number:
WO 2014/185797 (20.11.2014 Gazette 2014/47)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 17.05.2013 PL 40394213
30.04.2014 PL 40808914

(71) Applicant: Instytut Farmaceutyczny
01-793 Warsawa (PL)

(72) Inventors:
  • MICHALAK, Olga
    04-847 Warszawa (PL)
  • JATCZAK, Kamil
    05-800 Pruszków (PL)
  • PUCKO, Wieslaw
    01-461 Warszawa (PL)
  • WITKOWSKA, Anna
    01-905 Warszawa (PL)
  • LASZCZ, Marta
    03-126 Warszawa (PL)
  • BUJAK, Iwona
    02-132 Warszawa (PL)
  • GROMAN, Aleksandra
    03-565 Warszawa (PL)
  • CYBULSKI, Marcin
    03-254 Warszawa (PL)

(74) Representative: Krzywdzinska, Ewa 
Instytut Farmaceutyczny, ul. Rydygiera 8
01-793 Warszawa
01-793 Warszawa (PL)

   


(54) PROCESS FOR THE PREPARATION OF HIGH PURITY AMORPHOUS PEMETREXED DISODIUM AND CRYSTALLINE FORMS OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID